Sign Up
OverviewAPI
The global market for tumor ablation and radiation oncology devices is set to grow significantly, driven by the increasing prevalence of cancer, technological advancements, and supportive reimbursement programs. Companies like RAYDIAX are developing innovative imaging devices for minimally invasive cancer treatments, while the market is expected to reach billions of dollars in value by 2030.

Ask a question